Avanir's Struggle Was Worth It: Reformulated Zenvia Succeeds In Confirmatory Phase III

Once crushed by an FDA approvable letter for the emotional outburst therapy, the company has battled to stay afloat and now anticipates launching the drug in the second half of 2010.